Berkeley Capital Partners LLC Decreases Stock Holdings in Healthpeak Properties, Inc. $DOC

Berkeley Capital Partners LLC lowered its stake in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 53.2% during the fourth quarter, Holdings Channel reports. The institutional investor owned 37,465 shares of the real estate investment trust’s stock after selling 42,528 shares during the period. Berkeley Capital Partners LLC’s holdings in Healthpeak Properties were worth $602,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. CoreCap Advisors LLC boosted its holdings in Healthpeak Properties by 22.4% during the third quarter. CoreCap Advisors LLC now owns 3,352 shares of the real estate investment trust’s stock worth $64,000 after buying an additional 613 shares in the last quarter. Fiduciary Trust Co boosted its holdings in Healthpeak Properties by 4.9% during the third quarter. Fiduciary Trust Co now owns 13,807 shares of the real estate investment trust’s stock worth $264,000 after buying an additional 644 shares in the last quarter. Patton Fund Management Inc. boosted its holdings in Healthpeak Properties by 5.2% during the fourth quarter. Patton Fund Management Inc. now owns 13,002 shares of the real estate investment trust’s stock worth $209,000 after buying an additional 648 shares in the last quarter. Arjuna Capital boosted its holdings in Healthpeak Properties by 4.8% during the third quarter. Arjuna Capital now owns 14,768 shares of the real estate investment trust’s stock worth $283,000 after buying an additional 679 shares in the last quarter. Finally, Quadrant Capital Group LLC boosted its holdings in Healthpeak Properties by 1.9% during the third quarter. Quadrant Capital Group LLC now owns 37,650 shares of the real estate investment trust’s stock worth $721,000 after buying an additional 718 shares in the last quarter. Hedge funds and other institutional investors own 93.57% of the company’s stock.

Healthpeak Properties Stock Performance

Shares of DOC opened at $19.56 on Thursday. The company has a debt-to-equity ratio of 1.15, a quick ratio of 2.96 and a current ratio of 2.96. The company has a market capitalization of $13.48 billion, a price-to-earnings ratio of 61.11, a PEG ratio of 2.73 and a beta of 1.00. The company’s 50 day simple moving average is $17.19 and its 200 day simple moving average is $17.19. Healthpeak Properties, Inc. has a 1 year low of $15.70 and a 1 year high of $19.87.

Healthpeak Properties (NYSE:DOC) last announced its quarterly earnings data on Tuesday, May 5th. The real estate investment trust reported $0.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.43 by $0.02. The business had revenue of $752.95 million for the quarter, compared to the consensus estimate of $694.59 million. Healthpeak Properties had a net margin of 7.73% and a return on equity of 2.61%. The company’s quarterly revenue was up 7.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.46 earnings per share. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. On average, sell-side analysts predict that Healthpeak Properties, Inc. will post 1.74 EPS for the current year.

Healthpeak Properties Dividend Announcement

The business also recently declared a monthly dividend, which will be paid on Friday, June 26th. Investors of record on Monday, June 15th will be given a dividend of $0.1017 per share. The ex-dividend date of this dividend is Monday, June 15th. This represents a c) annualized dividend and a yield of 6.2%. Healthpeak Properties’s dividend payout ratio is 381.25%.

Analyst Ratings Changes

A number of research firms recently commented on DOC. Morgan Stanley decreased their price objective on shares of Healthpeak Properties from $21.00 to $18.00 and set an “overweight” rating on the stock in a report on Tuesday, April 28th. Citigroup boosted their price objective on shares of Healthpeak Properties from $17.50 to $20.00 and gave the stock a “neutral” rating in a report on Tuesday. Robert W. Baird boosted their price objective on shares of Healthpeak Properties from $19.00 to $21.00 and gave the stock an “outperform” rating in a report on Wednesday. Scotiabank raised shares of Healthpeak Properties to a “hold” rating in a report on Thursday, April 23rd. Finally, Wall Street Zen raised shares of Healthpeak Properties from a “sell” rating to a “hold” rating in a report on Sunday. Four analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $18.75.

Insiders Place Their Bets

In other Healthpeak Properties news, insider Scott R. Bohn sold 10,989 shares of the stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of $19.45, for a total transaction of $213,736.05. Following the transaction, the insider owned 7,636 shares of the company’s stock, valued at $148,520.20. This trade represents a 59.00% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 0.23% of the stock is currently owned by corporate insiders.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.